Brian S Levitt, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location · San Jose Gastroenterology, Inc. · 11 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Levitt’s office at (408) 347-9001 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A99206 · Current
Licensed to practise in California · since 2007 · expires 2028-07-31 · University of Massachusetts Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Montpelier Surgery Center, IncAmbulatory Surgery Center · San Jose, CA13% owner since 2009 · accredited by AAAHCAccreditation Renewed3 inspections · last 2023-05-25
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$104,812
Medicare paid this office $104,812 for 317 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 99 | $22,013 | $220 |
| Pathology examination of tissue using a microscope, intermediate complexity | 151 | $17,064 | $40 |
| New patient visit (45+ min) | 61 | $8,595 | $141 |
| New patient visit (30+ min) | 94 | $8,571 | $91 |
| Biopsy of large bowel using a flexible endoscope | 83 | $6,762 | $81 |
See all 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 99 | $22,013 | $220 |
| Pathology examination of tissue using a microscope, intermediate complexity | 151 | $17,064 | $40 |
| New patient visit (45+ min) | 61 | $8,595 | $141 |
| New patient visit (30+ min) | 94 | $8,571 | $91 |
| Biopsy of large bowel using a flexible endoscope | 83 | $6,762 | $81 |
| Return visit (30+ min) | 52 | $6,720 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 69 | $5,820 | $82 |
| Short return visit (20+ min) | 63 | $5,104 | $76 |
| Special stained specimen slides to identify organisms including interpretation and report | 22 | $3,794 | $97 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $3,262 | $155 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 76 | $369 | $5 |
Procedures Medicare counted
| Colonoscopy | 241 | More than 96% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 74 | More than 71% of doctors who do this |
Who their Medicare patients are
317 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 4% · Women 53% · Also on Medicaid 22% · Health risk score 1.07. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 74% · Diabetes 30% · Coronary heart disease 26% · Chronic kidney disease 21% · Atrial fibrillation 14% · Depression 13% · Heart failure 11% · Cancer 10% · COPD 9% · Stroke 6% · Dementia 5%.
The office billed $584,254, Medicare allowed $136,851 and paid $104,812; for 1,202 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 317 | 1,202 | 74 | 1.07 | $584,254 | $104,812 |
| 2023 | 327 | 1,194 | 73 | 1.11 | $388,163 | $100,060 |
| 2022 | 334 | 1,164 | 74 | 1.30 | $388,616 | $102,396 |
| 2021 | 328 | 1,078 | 74 | 1.28 | $340,643 | $98,815 |
| 2020 | 275 | 940 | 75 | 1.73 | $319,038 | $85,794 |
| 2019 | 396 | 1,480 | 74 | 1.52 | $513,504 | $139,834 |
| 2018 | 438 | 1,783 | 73 | 1.25 | $572,147 | $156,751 |
| 2017 | 446 | 1,974 | 73 | 1.58 | $664,008 | $178,898 |
| 2016 | 394 | 1,274 | 73 | 1.49 | $486,089 | $140,894 |
| 2015 | 375 | 1,162 | 73 | 1.61 | $433,551 | $132,985 |
| 2014 | 447 | 1,469 | 72 | 1.43 | $472,610 | $161,269 |
| 2013 | 470 | 1,560 | 73 | 1.63 | $356,774 | $164,355 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 111 | $24,835 | $222 |
| Pathology examination of tissue using a microscope, intermediate complexity | 162 | $16,569 | $38 |
| New patient visit (45+ min) | 67 | $10,090 | $151 |
| Return visit (30+ min) | 68 | $8,132 | $111 |
| New patient visit (30+ min) | 67 | $5,729 | $86 |
| Biopsy of large bowel using a flexible endoscope | 86 | $5,709 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $5,302 | $90 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $3,792 | $165 |
| Short return visit (20+ min) | 33 | $2,647 | $80 |
| New patient visit (15+ min) | 29 | $1,423 | $49 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 100 | $464 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $203 | $14 |
2022: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 93 | $20,704 | $220 |
| Pathology examination of tissue using a microscope, intermediate complexity | 132 | $13,167 | $37 |
| New patient visit (45+ min) | 66 | $9,888 | $150 |
| Return visit (30+ min) | 65 | $9,269 | $119 |
| New patient visit (30+ min) | 62 | $5,296 | $85 |
| Biopsy of large bowel using a flexible endoscope | 63 | $5,142 | $80 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $4,783 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,308 | $180 |
| Short return visit (20+ min) | 41 | $3,570 | $76 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,527 | $160 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $2,115 | $96 |
| New patient visit (15+ min) | 27 | $1,778 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,772 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,358 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $902 | $82 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 103 | $481 | $5 |
2021: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | $12,785 | $220 |
| Return visit (30+ min) | 76 | $11,135 | $122 |
| Pathology examination of tissue using a microscope, intermediate complexity | 101 | $10,261 | $37 |
| New patient visit (45+ min) | 68 | $9,997 | $147 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,026 | $183 |
| New patient visit (30+ min) | 60 | $5,881 | $98 |
| Biopsy of large bowel using a flexible endoscope | 64 | $5,779 | $90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $5,365 | $88 |
| Short return visit (20+ min) | 52 | $4,558 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,362 | $94 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,312 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,299 | $66 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $1,712 | $95 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,315 | $101 |
| New patient visit (15+ min) | 14 | $792 | $57 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 79 | $396 | $5 |
2020: 15 services
| Pathology examination of tissue using a microscope, intermediate complexity | 86 | $12,575 | $47 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 50 | $11,051 | $221 |
| New patient visit (45+ min) | 58 | $8,193 | $141 |
| Return visit (30+ min) | 62 | $7,258 | $98 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | $6,134 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,390 | $186 |
| Biopsy of large bowel using a flexible endoscope | 48 | $4,943 | $103 |
| New patient visit (30+ min) | 40 | $3,174 | $79 |
| Short return visit (20+ min) | 45 | $2,988 | $60 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,163 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,079 | $95 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $1,232 | $103 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,078 | $90 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 77 | $385 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $164 | $15 |
2019: 16 services
| Pathology examination of tissue using a microscope, intermediate complexity | 141 | $26,574 | $68 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 95 | $21,413 | $225 |
| Return visit (30+ min) | 86 | $9,915 | $97 |
| New patient visit (45+ min) | 72 | $9,741 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,057 | $181 |
| Biopsy of large bowel using a flexible endoscope | 92 | $7,092 | $77 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 70 | $6,286 | $89 |
| Short return visit (20+ min) | 55 | $4,269 | $68 |
| New patient visit (30+ min) | 44 | $4,115 | $94 |
| Special stained specimen slides to identify organisms including interpretation and report | 27 | $3,631 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,165 | $93 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $2,862 | $151 |
| New patient visit (15+ min) | 38 | $2,506 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,150 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,192 | $85 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 127 | $635 | $5 |
2018: 22 services
| Pathology examination of tissue using a microscope, intermediate complexity | 153 | $28,232 | $67 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 102 | $23,558 | $229 |
| New patient visit (45+ min) | 65 | $9,454 | $145 |
| Biopsy of large bowel using a flexible endoscope | 94 | $8,585 | $90 |
| Return visit (30+ min) | 76 | $8,168 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,004 | $182 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $7,250 | $93 |
| New patient visit (30+ min) | 87 | $6,996 | $80 |
| Short return visit (20+ min) | 68 | $5,242 | $66 |
| Diagnostic exam of large bowel using a flexible endoscope | 33 | $5,101 | $150 |
| Special stained specimen slides to identify organisms including interpretation and report | 29 | $3,931 | $101 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,722 | $207 |
| Special stained specimen slides to examine tissue, initial procedure | 16 | $2,021 | $112 |
| New patient visit (15+ min) | 35 | $1,995 | $57 |
| Microscopic genetic analysis of tumor, manual | 12 | $1,650 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,404 | $94 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,369 | $81 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 95 | $1,308 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,046 | $65 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 173 | $874 | $5 |
| New patient visit (10+ min) | 22 | $819 | $37 |
| Injection beneath lining of large bowel using a flexible endoscope | 15 | $231 | $15 |
2017: 23 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 103 | $23,811 | $227 |
| Pathology examination of tissue using a microscope, intermediate complexity | 140 | $23,713 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,509 | $181 |
| Imaging of digestive tract done from the inside of the digestive tract | 14 | $11,779 | $841 |
| New patient visit (45+ min) | 89 | $11,715 | $132 |
| New patient visit (30+ min) | 93 | $8,190 | $88 |
| Biopsy of large bowel using a flexible endoscope | 103 | $7,988 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $6,689 | $87 |
| Return visit (30+ min) | 56 | $6,228 | $96 |
| Short return visit (20+ min) | 72 | $5,590 | $65 |
| Special stained specimen slides to identify organisms including interpretation and report | 33 | $4,655 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,365 | $93 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,761 | $212 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,335 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,332 | $65 |
| Special stained specimen slides to examine tissue, initial procedure | 13 | $1,748 | $103 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,742 | $158 |
| New patient visit (15+ min) | 24 | $1,289 | $54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 77 | $1,071 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 79 | $916 | $11 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $723 | $52 |
| New patient visit (10+ min) | 15 | $549 | $37 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 103 | $509 | $5 |
2016: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 122 | $21,330 | $72 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 80 | $18,294 | $229 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $9,144 | $112 |
| Biopsy of large bowel using a flexible endoscope | 93 | $8,909 | $96 |
| New patient visit (30+ min) | 99 | $8,772 | $89 |
| New patient visit (45+ min) | 55 | $8,232 | $150 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,931 | $180 |
| Return visit (30+ min) | 59 | $6,765 | $95 |
| Short return visit (20+ min) | 79 | $6,114 | $64 |
| Special stained specimen slides to identify organisms including interpretation and report | 36 | $4,596 | $96 |
| Microscopic genetic analysis of tumor, manual | 22 | $2,995 | $120 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,610 | $218 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,282 | $207 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,759 | $93 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,711 | $101 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $1,626 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,543 | $64 |
| New patient visit (15+ min) | 27 | $1,469 | $54 |
2015: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 57 | $15,495 | $263 |
| Biopsy of large bowel using a flexible endoscope | 80 | $12,096 | $149 |
| Pathology examination of tissue using a microscope, intermediate complexity | 100 | $11,977 | $55 |
| Imaging of digestive tract done from the inside of the digestive tract | 13 | $11,706 | $900 |
| New patient visit (30+ min) | 100 | $8,387 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,203 | $178 |
| New patient visit (45+ min) | 55 | $7,946 | $144 |
| Short return visit (20+ min) | 95 | $7,485 | $62 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 68 | $6,797 | $100 |
| Return visit (30+ min) | 59 | $6,030 | $90 |
| Special stained specimen slides to identify organisms including interpretation and report | 29 | $3,330 | $90 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $3,187 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,109 | $92 |
| Special stained specimen slides to examine tissue including interpretation and report | 26 | $2,053 | $60 |
| New patient visit (15+ min) | 24 | $1,677 | $70 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,656 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,428 | $62 |
| Measurement of liver stiffness | 15 | $526 | $35 |
2014: 22 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $20,066 | $264 |
| Biopsy of large bowel using a flexible endoscope | 100 | $13,992 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $12,411 | $180 |
| Short return visit (20+ min) | 133 | $11,103 | $66 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $10,881 | $907 |
| New patient visit (30+ min) | 122 | $10,853 | $89 |
| Pathology examination of tissue using a microscope, intermediate complexity | 125 | $9,349 | $33 |
| New patient visit (45+ min) | 60 | $8,822 | $147 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $8,071 | $105 |
| Return visit (30+ min) | 48 | $5,168 | $98 |
| Removal of external hemorrhoids by rubber banding | 12 | $5,146 | $257 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $3,854 | $241 |
| Special stained specimen slides to examine tissue including interpretation and report | 44 | $3,590 | $56 |
| Special stained specimen slides to identify organisms including interpretation and report | 39 | $3,020 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,690 | $64 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,390 | $100 |
| Complete ultrasound scan of abdomen | 16 | $2,292 | $143 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,014 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,756 | $92 |
| New patient visit (15+ min) | 23 | $1,491 | $65 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $561 | $40 |
| New patient visit (10+ min) | 13 | $494 | $38 |
2013: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 82 | $22,377 | $263 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $12,802 | $175 |
| Biopsy of large bowel using a flexible endoscope | 88 | $11,870 | $133 |
| New patient visit (45+ min) | 76 | $11,389 | $150 |
| Short return visit (20+ min) | 134 | $11,229 | $65 |
| Pathology examination of tissue using a microscope, intermediate complexity | 125 | $10,514 | $34 |
| New patient visit (30+ min) | 112 | $10,468 | $93 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 71 | $9,063 | $119 |
| Return visit (30+ min) | 68 | $8,236 | $98 |
| Special stained specimen slides to examine tissue including interpretation and report | 46 | $4,336 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $4,311 | $62 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,589 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,504 | $90 |
| Special stained specimen slides to identify organisms including interpretation and report | 37 | $3,139 | $75 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $2,045 | $114 |
| New patient visit (15+ min) | 18 | $1,199 | $67 |
| Incision of pancreatic outlet using a flexible endoscope | 11 | $1,093 | $99 |
| New patient visit (10+ min) | 13 | $469 | $36 |
| Injection beneath lining of large bowel using a flexible endoscope | 17 | $452 | $27 |
Medicaid work
$30 in 2018
Medicaid paid $30 for 14 billed services this clinician did in 2018, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 14 | $30 |
| 2018 | 14 | 1 | 13 | $30 |
Drugs they prescribed that Part D paid
$174,209
Pharmacies billed $174,209 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 731) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
558 generic and 173 brand-name prescriptions · $174,209 in drug cost · 20 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 41 | $65,640 | $1,601 |
| Linzess | 33 | $21,309 | $646 |
| Mesalamine | 12 | $9,091 | $758 |
| Sod Sulf-Potass Sulf-Mag Sulf | 126 | $8,291 | $66 |
| Entecavir | 30 | $2,388 | $80 |
See all 11 drugs
| Vemlidy | 41 | $65,640 | $1,601 |
| Linzess | 33 | $21,309 | $646 |
| Mesalamine | 12 | $9,091 | $758 |
| Sod Sulf-Potass Sulf-Mag Sulf | 126 | $8,291 | $66 |
| Entecavir | 30 | $2,388 | $80 |
| Pantoprazole | 136 | $2,123 | $16 |
| Omeprazole | 86 | $1,230 | $14 |
| Gavilyte-G | 78 | $1,171 | $15 |
| Peg-3350 and Electrolytes | 29 | $420 | $14 |
| Mercaptopurine | 11 | $373 | $34 |
| Famotidine | 19 | $129 | $7 |
Year by year
| 2024 | 731 | 342 | 0% (0) | 24% | $174,209 |
| 2023 | 631 | 288 | 0% (0) | 28% | $160,173 |
| 2022 | 747 | 294 | None | None | $385,964 |
| 2021 | 689 | 237 | 0% (0) | None | $270,531 |
| 2020 | 677 | 261 | 0% (0) | None | $283,916 |
| 2019 | 708 | 267 | 0% (0) | 29% | $482,955 |
| 2018 | 626 | 285 | 0% (0) | 33% | $289,333 |
| 2017 | 613 | 300 | 0% (0) | 34% | $371,267 |
| 2016 | 597 | 279 | 0% (0) | 36% | $697,702 |
| 2015 | 685 | 289 | 0% (0) | 38% | $1,153,435 |
| 2014 | 702 | 274 | None | None | $233,070 |
| 2013 | 612 | 233 | None | 34% | $58,627 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Vemlidy | 50 | $70,737 | $1,415 |
| Linzess | 33 | $22,990 | $697 |
| Mesalamine | 12 | $9,211 | $768 |
| Sod Sulf-Potass Sulf-Mag Sulf | 77 | $5,998 | $78 |
| Pantoprazole | 139 | $5,418 | $39 |
| Sutab | 31 | $5,152 | $166 |
| Entecavir | 23 | $2,157 | $94 |
| Omeprazole | 80 | $1,213 | $15 |
| Gavilyte-G | 49 | $838 | $17 |
| Famotidine | 20 | $219 | $11 |
2022: 15 drugs
| Vemlidy | 55 | $76,005 | $1,382 |
| Entecavir | 24 | $18,718 | $780 |
| Linzess | 16 | $8,355 | $522 |
| Mesalamine Er | 19 | $8,069 | $425 |
| Pantoprazole | 186 | $7,068 | $38 |
| Lubiprostone | 11 | $6,804 | $619 |
| Suprep | 36 | $4,101 | $114 |
| Omeprazole | 105 | $1,421 | $14 |
| Sod Sulf-Potass Sulf-Mag Sulf | 15 | $1,297 | $86 |
| Peg-3350 and Electrolytes | 45 | $644 | $14 |
| Gavilyte-G | 45 | $606 | $13 |
| Gavilyte-C | 11 | $195 | $18 |
| Metronidazole | 14 | $162 | $12 |
| Dicyclomine | 12 | $89 | $7 |
| Famotidine | 14 | $77 | $5 |
2021: 14 drugs
| Vemlidy | 45 | $56,265 | $1,250 |
| Linzess | 31 | $15,198 | $490 |
| Entecavir | 12 | $11,848 | $987 |
| Mesalamine Er | 16 | $9,040 | $565 |
| Mesalamine | 14 | $5,735 | $410 |
| Suprep | 49 | $5,329 | $109 |
| Pantoprazole | 161 | $2,694 | $17 |
| Balsalazide Disodium | 12 | $1,323 | $110 |
| Omeprazole | 121 | $1,150 | $10 |
| Peg 3350-Electrolyte | 29 | $565 | $19 |
| Famotidine | 21 | $332 | $16 |
| Peg-3350 and Electrolytes | 18 | $237 | $13 |
| Gavilyte-G | 20 | $221 | $11 |
| Prednisone | 12 | $68 | $6 |
2020: 12 drugs
| Xifaxan | 22 | $47,451 | $2,157 |
| Vemlidy | 36 | $42,721 | $1,187 |
| Linzess | 23 | $10,743 | $467 |
| Suprep | 63 | $6,532 | $104 |
| Mesalamine | 16 | $5,590 | $349 |
| Mesalamine Er | 13 | $4,997 | $384 |
| Pantoprazole | 162 | $1,817 | $11 |
| Omeprazole | 97 | $894 | $9 |
| Gavilyte-G | 59 | $765 | $13 |
| Famotidine | 26 | $296 | $11 |
| Peg-3350 and Electrolytes | 23 | $289 | $13 |
| Peg 3350-Electrolyte | 17 | $283 | $17 |
2019: 13 drugs
| Xifaxan | 24 | $46,389 | $1,933 |
| Vemlidy | 38 | $42,076 | $1,107 |
| Apriso | 23 | $16,074 | $699 |
| Delzicol | 11 | $14,205 | $1,291 |
| Mesalamine | 18 | $11,524 | $640 |
| Entecavir | 11 | $10,293 | $936 |
| Suprep | 43 | $4,177 | $97 |
| Pantoprazole | 164 | $1,592 | $10 |
| Gavilyte-G | 102 | $1,491 | $15 |
| Omeprazole | 89 | $926 | $10 |
| Ranitidine | 11 | $165 | $15 |
| Peg-3350 and Electrolytes | 14 | $162 | $12 |
| Metronidazole | 12 | $157 | $13 |
2018: 11 drugs
| Vemlidy | 31 | $33,512 | $1,081 |
| Apriso | 29 | $16,381 | $565 |
| Dipentum | 12 | $4,923 | $410 |
| Suprep | 26 | $2,450 | $94 |
| Pantoprazole | 140 | $1,315 | $9 |
| Gavilyte-G | 96 | $1,259 | $13 |
| Omeprazole | 62 | $635 | $10 |
| Peg 3350-Electrolyte | 32 | $603 | $19 |
| Peg-3350 and Electrolytes | 35 | $421 | $12 |
| Ranitidine | 14 | $305 | $22 |
| Gavilyte-N | 12 | $232 | $19 |
2017: 12 drugs
| Vemlidy | 11 | $10,985 | $999 |
| Dipentum | 12 | $4,768 | $397 |
| Tetracycline | 12 | $4,488 | $374 |
| Suprep | 18 | $1,581 | $88 |
| Gavilyte-G | 99 | $1,395 | $14 |
| Pantoprazole | 84 | $914 | $11 |
| Peg-3350 and Electrolytes | 71 | $872 | $12 |
| Omeprazole | 85 | $770 | $9 |
| Peg 3350-Electrolyte | 19 | $309 | $16 |
| Metronidazole | 16 | $208 | $13 |
| Gavilyte-N | 11 | $202 | $18 |
| Dicyclomine | 19 | $52 | $3 |
2016: 15 drugs
| Harvoni | 17 | $536,682 | $31,570 |
| Xifaxan | 11 | $20,762 | $1,887 |
| Viread | 13 | $13,010 | $1,001 |
| Dipentum | 12 | $4,673 | $389 |
| Ursodiol | 11 | $4,645 | $422 |
| Suprep | 37 | $3,088 | $83 |
| Omeprazole | 119 | $683 | $6 |
| Gavilyte-G | 47 | $683 | $15 |
| Pantoprazole | 74 | $648 | $9 |
| Peg-3350 and Electrolytes | 49 | $601 | $12 |
| Peg 3350-Electrolyte | 26 | $444 | $17 |
| Gavilyte-N | 23 | $426 | $19 |
| Sulfasalazine | 21 | $413 | $20 |
| Ranitidine | 13 | $327 | $25 |
| Generlac | 11 | $137 | $12 |
2015: 17 drugs
| Harvoni | 21 | $674,558 | $32,122 |
| Sovaldi | 11 | $310,140 | $28,195 |
| Baraclude | 24 | $25,083 | $1,045 |
| Xifaxan | 15 | $24,117 | $1,608 |
| Dipentum | 12 | $4,226 | $352 |
| Creon | 13 | $2,128 | $164 |
| Gavilyte-G | 71 | $987 | $14 |
| Peg-3350 and Electrolytes | 63 | $858 | $14 |
| Pantoprazole | 90 | $813 | $9 |
| Omeprazole | 124 | $746 | $6 |
| Peg 3350-Electrolyte | 32 | $629 | $20 |
| Clarithromycin | 11 | $552 | $50 |
| Metronidazole | 13 | $478 | $37 |
| Ranitidine | 19 | $341 | $18 |
| Lactulose | 13 | $332 | $26 |
| Sulfasalazine | 12 | $287 | $24 |
| Amoxicillin | 12 | $88 | $7 |
2014: 12 drugs
| Baraclude | 24 | $23,653 | $986 |
| Lialda | 17 | $10,674 | $628 |
| Delzicol | 12 | $10,625 | $885 |
| Creon | 13 | $1,417 | $109 |
| Pantoprazole | 99 | $1,412 | $14 |
| Peg-3350 and Electrolytes | 92 | $1,383 | $15 |
| Omeprazole | 169 | $1,353 | $8 |
| Peg-3350 | 22 | $404 | $18 |
| Gavilyte-G | 25 | $366 | $15 |
| Ranitidine | 18 | $224 | $12 |
| Peg 3350-Electrolyte | 17 | $198 | $12 |
| Gavilyte-N | 11 | $191 | $17 |
2013: 12 drugs
| Baraclude | 12 | $12,493 | $1,041 |
| Lialda | 16 | $8,101 | $506 |
| Nexium | 17 | $6,928 | $408 |
| Pantoprazole | 88 | $1,988 | $23 |
| Omeprazole | 120 | $1,350 | $11 |
| Creon | 11 | $1,120 | $102 |
| Peg-3350 With Flavor Packs | 47 | $971 | $21 |
| Peg-3350 and Electrolytes | 52 | $817 | $16 |
| Ondansetron | 14 | $358 | $26 |
| Gavilyte-N | 17 | $353 | $21 |
| Famotidine | 28 | $265 | $9 |
| Furosemide | 11 | $45 | $4 |
Money from drug and device companies
$445 in 2025
| 2025 | 7 | 21 | None | $445 |
| 2024 | 1 | 1 | None | $21 |
| 2023 | 3 | 10 | None | $247 |
| 2022 | 2 | 5 | None | $105 |
| 2021 | 3 | 29 | None | $259 |
| 2019 | 2 | 5 | None | $157 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Linzess | $158 | 10 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $116 | 5 payments
|
| Gilead Sciences | None | $43 | 2 payments
|
| Janssen Biotech | Tremfya | $40 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $34 | 1 payment
|
| Lilly USA | Omvoh | $33 | 1 payment
|
See all 21 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-11-17 | Xifaxan | $22 |
| Abbvie | Meals · 2025-11-12 | Linzess | $22 |
| Gilead Sciences | Meals · 2025-11-03 | None | $25 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-22 | Xifaxan | $23 |
| Abbvie | Meals · 2025-09-11 | Linzess | $15 |
| Phathom Pharmaceuticals | Meals · 2025-09-09 | Voquezna | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-14 | Entyvio | $34 |
| Gilead Sciences | Meals · 2025-08-11 | None | $18 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-08 | Xifaxan | $24 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-27 | Xifaxan | $23 |
| Abbvie | Meals · 2025-05-22 | Creon | $23 |
| Abbvie | Meals · 2025-04-23 | Linzess | $5 |
| Abbvie | Meals · 2025-04-12 | Skyrizi | $31 |
| Janssen Biotech | Meals · 2025-04-08 | Tremfya | $40 |
| Lilly USA | Meals · 2025-04-08 | Omvoh | $33 |
| Abbvie | Meals · 2025-03-19 | Linzess | $14 |
| Abbvie | Meals · 2025-03-15 | Linzess | $6 |
| Abbvie | Meals · 2025-03-04 | Linzess | $20 |
| Abbvie | Meals · 2025-02-28 | Linzess | $2 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-01-23 | Xifaxan | $24 |
| Abbvie | Meals · 2025-01-15 | Linzess | $20 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $21
| Gilead Sciences | None | $21 | 1 payment
|
2023: $247
| Gilead Sciences | None | $127 | 4 payments
|
| Abbvie | Mavyret | $99 | 5 payments
|
| Pfizer | Xeljanz | $21 | 1 payment
|
2022: $105
| Abbvie | Rinvoq | $85 | 4 payments
|
| Gilead Sciences | None | $20 | 1 payment
|
2021: $259
| Gilead Sciences | None | $208 | 26 payments
|
| AbbVie | Humira | $33 | 2 payments
|
| Janssen Biotech | Stelara | $18 | 1 payment
|
2019: $157
| Gilead Sciences | Vemlidy | $135 | 4 payments
|
| AbbVie | Mavyret | $22 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 97.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Age Appropriate Screening ColonoscopyAs Medicare defines this measure | 0% | 873 |
| Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk PatientsAs Medicare defines this measure | 100% | 81 |
| Colon cancer screeningEligible adults who got a colon cancer test | 100%That's most of the people this applied to. | 882 |
| Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate UseAs Medicare defines this measure | 100% | 187 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 1,391 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,160 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Improved the patient portal
- Offers telehealth visits
Professional record
- NPI
- 1235257759
- Licence
- CA A99206California A99206: Current · expires 2028-07-31
- Trained
- University of Massachusetts Medical School, 2001
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A992060
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2340 Montpelier Dr, Suite A, San Jose, CA, 95116
- NPI first listed
- 2007-03-26
- NPI last updated
- 2023-11-07
- NPI record certified
- 2023-11-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2331 Montpelier Dr Ste B, San Jose, CA, 95116